Details for New Drug Application (NDA): 020822
✉ Email this page to a colleague
NDA 020822 describes CELEXA, which is a drug marketed by Forest Labs and Abbvie and is included in two NDAs. It is available from one supplier. Additional details are available on the CELEXA profile page.
The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
Summary for 020822
| Tradename: | CELEXA |
| Applicant: | Abbvie |
| Ingredient: | citalopram hydrobromide |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 020822
| Mechanism of Action | Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 020822
Suppliers and Packaging for NDA: 020822
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822 | NDA | Allergan, Inc. | 0456-4010 | 0456-4010-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0456-4010-01) |
| CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822 | NDA | Allergan, Inc. | 0456-4020 | 0456-4020-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0456-4020-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Apr 27, 2000 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
| Approval Date: | Jul 17, 1998 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 40MG BASE | ||||
| Approval Date: | Jul 17, 1998 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
